WOW!

 Linda and Carolyn on Dungeness Spit

This is such good news that I can hardly believe it!  Scientists at Memorial Slone Kettering Cancer Center (possibly the best of them all) have run a small clinical study to test the efficacy of a new drug called dostarlimab against rectal cancer.  Dostarlimab belongs to a class of drug known as checkpoint inhibitors – Google it, if confused.  The drug currently is manufactured by Big Pharma member GlaxoSmithKline, which financed the trial.  Eighteen people were involved – a tiny number – BUT every one of them achieved full remission.  Cancer gone, completely!  And furthermore, no serious side effects were noted.  This kind of result has no verifiable precedent!  Of course, more testing is required, but ….Jeez!

Read this article.  You will be glad you did.

The link I gave you (above) doesn’t appear to work.  This one does.

https://abc7ny.com/memorial-sloan-kettering-cancer-center-rectal-immunotherapy-msk/11935554/  

Linda’s sister Carolyn Joyce alerted me to this important bit of news.